CORNERSTONE program integrates process development expertise and novel technology to remove development bottlenecks in the manufacture of Gene Therapy Medicinal Products (GTMPs)
CURRENT ISSUE - January/February 2026
Applying the Six Cs Helps Labs Deliver Results Stakeholders Can Rely On